TY - JOUR
T1 - Balloon Angioplasty in Acute and Chronic Coronary Artery Disease
AU - Holmes, David R.
AU - Vlietstra, Ronald E.
PY - 1989/4/14
Y1 - 1989/4/14
N2 - Percutaneous transluminal coronary angioplasty has grown exponentially since its introduction. Currently, selection criteria include single-vessel and multivessel disease, stable and unstable angina, and acute infarction. The outcome depends on specific patient and angiographic characteristics. In ideal lesions, success rates should be greater than 90%, with low morbidity and mortality. With more severe and diffuse multivessel disease, success rates are lower and complication rates are higher. In these cases, percutaneous transluminal coronary angioplasty still offers a reasonable option, provided complete revascularization can be achieved or the angina-producing lesion dilated. Numerous issues remain unresolved, including (1) the role of percutaneous transluminal coronary angioplasty vs coronary surgery (currently being tested), (2) restenosis, which occurs in approximately 30% of treated lesions, and (3) organizational adjustments such as training and certification to maintain high standards of care.
AB - Percutaneous transluminal coronary angioplasty has grown exponentially since its introduction. Currently, selection criteria include single-vessel and multivessel disease, stable and unstable angina, and acute infarction. The outcome depends on specific patient and angiographic characteristics. In ideal lesions, success rates should be greater than 90%, with low morbidity and mortality. With more severe and diffuse multivessel disease, success rates are lower and complication rates are higher. In these cases, percutaneous transluminal coronary angioplasty still offers a reasonable option, provided complete revascularization can be achieved or the angina-producing lesion dilated. Numerous issues remain unresolved, including (1) the role of percutaneous transluminal coronary angioplasty vs coronary surgery (currently being tested), (2) restenosis, which occurs in approximately 30% of treated lesions, and (3) organizational adjustments such as training and certification to maintain high standards of care.
UR - http://www.scopus.com/inward/record.url?scp=0024544003&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024544003&partnerID=8YFLogxK
U2 - 10.1001/jama.1989.03420140111037
DO - 10.1001/jama.1989.03420140111037
M3 - Article
C2 - 2522564
AN - SCOPUS:0024544003
SN - 0098-7484
VL - 261
SP - 2109
EP - 2115
JO - JAMA: The Journal of the American Medical Association
JF - JAMA: The Journal of the American Medical Association
IS - 14
ER -